Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients

Cécile Pochon, Sebastian Voigt, Cécile Pochon, Sebastian Voigt

Abstract

Highly immunocompromised pediatric and adult hematopoietic cell transplant (HCT) recipients frequently experience respiratory infections caused by viruses that are less virulent in immunocompetent individuals. Most of these infections, with the exception of rhinovirus as well as adenovirus and parainfluenza virus in tropical areas, are seasonal variable and occur before and after HCT. Infectious disease management includes sampling of respiratory specimens from nasopharyngeal washes or swabs as well as sputum and tracheal or tracheobronchial lavages. These are subjected to improved diagnostic tools including multiplex PCR assays that are routinely used allowing for expedient detection of all respiratory viruses. Disease progression along with high mortality is frequently associated with respiratory syncytial virus, parainfluenza virus, influenza virus, and metapneumovirus infections. In this review, we discuss clinical findings and the appropriate use of diagnostic measures. Additionally, we also discuss treatment options and suggest new drug formulations that might prove useful in treating respiratory viral infections. Finally, we shed light on the role of the state of immune reconstitution and on the use of immunosuppressive drugs on the outcome of infection.

Keywords: antiviral therapy; co-infection; hematopoietic cell transplantation; immunosuppression; infection outcome; investigational drugs; respiratory virus infection.

References

    1. Abandeh F. I., Lustberg M., Devine S., Elder P., Andritsos L., Martin S. I. (2013). Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case-control study. Bone Marrow Transplant. 48 1554–1557. 10.1038/bmt.2013.100
    1. Abbas S., Raybould J. E., Sastry S., de la Cruz O. (2017). Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles. Int. J. Infect. Dis. 62 86–93. 10.1016/j.ijid.2017.07.011
    1. Abt M. C., Osborne L. C., Monticelli L. A., Doering T. A., Alenghat T., Sonnenberg G. F., et al. (2012). Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37 158–170. 10.1016/j.immuni.2012.04.011
    1. Aguayo-Hiraldo P. I., Arasaratnam R. J., Tzannou I., Kuvalekar M., Lulla P., Naik S., et al. (2017). Characterizing the cellular immune response to parainfluenza virus 3. J. Infect. Dis. 216 153–161. 10.1093/infdis/jix203
    1. Allander T. (2008). Human bocavirus. J. Clin. Virol. 41 29–33. 10.1016/j.jcv.2007.10.026
    1. Allander T., Tammi M. T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., Andersson B. (2005). Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl. Acad. Sci. U.S.A. 102 12891–12896. 10.1073/pnas.0504666102
    1. Arden K. E., McErlean P., Nissen M. D., Sloots T. P., Mackay I. M. (2006). Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J. Med. Virol. 78 1232–1240. 10.1002/jmv.20689
    1. Arthur J. L., Higgins G. D., Davidson G. P., Givney R. C., Ratcliff R. M. (2009). A novel bocavirus associated with acute gastroenteritis in Australian children. PLoS Pathog. 5:e1000391. 10.1371/journal.ppat.1000391
    1. Averbuch D., Safadi R., Dar D., Wolf D., Cherniak M., Sorek R., et al. (2018). Successful brincidofovir treatment of metagenomics-detected adenovirus infection in a severely Ill STAT1-deficient patient. Pediatr. Infect. Dis. J. 10.1097/INF.0000000000002090 [Epub ahead of print].
    1. Avetisyan G., Mattsson J., Sparrelid E., Ljungman P. (2009). Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome. Transplantation 88 1222–1226. 10.1097/TP.0b013e3181bb477e
    1. Bergeron A., Chevret S., Peffault de Latour R., Chagnon K., de Margerie-Mellon C., Rivière F., et al. (2018). Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation. Eur. Respir. J. 51:1702617. 10.1183/13993003.02617-2017
    1. Bicer S., Giray T., Col D., Erdag G. C., Vitrinel A., Gurol Y., et al. (2013). Virological and clinical characterizations of respiratory infections in hospitalized children. Ital. J. Pediatr. 39:22. 10.1186/1824-7288-39-22
    1. Birger R., Morita H., Comito D., Filip I., Galanti M., Lane B., et al. (2018). Asymptomatic shedding of respiratory virus among an ambulatory population across seasons. mSphere 3:e00667-18. 10.1128/mSphere.00249-18
    1. Boeckh M. (2008). The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br. J. Haematol. 143 455–467. 10.1111/j.1365-2141.2008.07295.x
    1. Boeckh M., Englund J. A., Li Y., Miller C., Cross A., Fernandez H., et al. (2007). Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin. Inf. Dis. 44 245–249. 10.1086/509930
    1. Boivin G., Abed Y., Pelletier G., Ruel L., Moisan D., Cote S., et al. (2002). Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J. Infect. Dis. 186 1330–1334. 10.1086/344319
    1. Bollard C. M., Heslop H. E. (2016). T cells for viral infections after allogeneic hematopoietic stem cell transplant. Blood 127 3331–3340. 10.1182/blood-2016-01-628982
    1. Bordigoni P., Carret A. S., Venard V., Witz F., Le Faou A. (2001). Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 32 1290–1297. 10.1086/319984
    1. Boudreault A. A., Xie H., Leisenring W., Englund J., Corey L., Boeckh M. (2011). Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus. Biol. Blood Marrow Transplant. 17 979–986. 10.1016/j.bbmt.2010.09.014
    1. Bredius R. G., Templeton K. E., Scheltinga S. A., Claas E. C., Kroes A. C., Vossen J. M. (2004). Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients. Pediatr. Infect. J. 23 518–522. 10.1097/
    1. Campbell A. P., Guthrie K. A., Englund J. A., Farney R. M., Minerich E. L., Kuypers J., et al. (2015). Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 61 192–202. 10.1093/cid/civ272
    1. Casper C., Englund J., Boeckh M. (2010). How I treat influenza in patients with hematologic malignancies. Blood 115 1331–1342. 10.1182/blood-2009-11-255455
    1. Chang P. V., Hao L., Offermanns S., Medzhitov R. (2014). The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. U.S.A. 111 2247–2252. 10.1073/pnas.1322269111
    1. Chemaly R. F., Ghosh S., Bodey G. P., Rohatgi N., Safdar A., Keating M. J., et al. (2006). Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Med. Baltim. 85 278–287. 10.1097/01.md.0000232560.22098.4e
    1. Chemaly R. F., Hanmod S. S., Rathod D. B., Ghantoji S. S., Jiang Y., Doshi A., et al. (2012). The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood 119 2738–2745. 10.1182/blood-2011-08-371112
    1. Chemaly R. F., Shah D. P., Boeckh M. J. (2014). Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 59(Suppl. 5) S344–S351. 10.1093/cid/ciu623
    1. Ching W., Koyuncu E., Singh S., Arbelo-Roman C., Hartl B., Kremmer E., et al. (2013). A ubiquitin-specific protease possesses a decisive role for adenovirus replication and oncogene-mediated transformation. PLoS Pathog. 9:e1003273. 10.1371/journal.ppat.1003273
    1. Choi J. H., Choi E. H., Kang H. J., Park K. D., Park S. S., Shin H. Y., et al. (2013). Respiratory viral infections after hematopoietic stem cell transplantation in children. J. Korean Med. Sci. 28 36–41. 10.3346/jkms.2013.28.1.36
    1. Choi S.-M., Boudreault A. A., Xie H., Englund J. A., Corey L., Boeckh M. (2011). Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 117 5050–5056. 10.1182/blood-2010-11-319186
    1. Choi S. M., Xie H., Campbell A. P., Kuypers J., Leisenring W., Boudreault A. A., et al. (2012). Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients. J. Infect. Dis. 206 1872–1877. 10.1093/infdis/jis610
    1. Chu H. Y., Renaud C., Ficken E., Thomson B., Kuypers J., Englund J. A. (2014). Respiratory tract infections due to human metapneumovirus in immunocompromised children. J. Pediatr. Infect. Soc. 3 286–293. 10.1093/jpids/piu100
    1. Cortez K. J., Erdman D. D., Peret T. C., Gill V. J., Childs R., Barrett A. J., et al. (2001). Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. J. Infect. Dis. 184 1093–1097. 10.1086/322041
    1. Cruz C. R. Y., Micklethwaite K. P., Savoldo B., Ramos C. A., Lam S., Ku S., et al. (2013). Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood 122 2965–2973. 10.1182/blood-2013-06-506741
    1. de Lima C. R., Mirandolli T. B., Carneiro L. C., Tusset C., Romer C. M., Andreolla H. F., et al. (2014). Prolonged respiratory viral shedding in transplant patients. Transplant. Infect. Dis. 16 165–169. 10.1111/tid.12167
    1. de Vries J. J., Bredius R. G., van Rheenen P. F., Smiers F. J., Scholvinck E. H., Vossen A. C., et al. (2009). Human bocavirus in an immunocompromised child presenting with severe diarrhea. J. Clin. Microbiol. 47 1241–1243. 10.1128/JCM.01703-08
    1. Debiaggi M., Canducci F., Sampaolo M., Marinozzi M. C., Parea M., Terulla C., et al. (2006). Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. J. Infect. Dis. 194 474–478. 10.1086/505881
    1. Debiaggi M., Canducci F., Terulla C., Sampaolo M., Marinozzi M. C., Alessandrino P. E., et al. (2007). Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. New Microbiol. 30 255–258.
    1. Detweiler C. J., Mueller S. B., Sung A. D., Saullo J. L., Prasad V. K., Cardona D. M. (2018). Brincidofovir (CMX001) toxicity associated with epithelial apoptosis and crypt drop out in a hematopoietic cell transplant patient: challenges in distinguishing drug toxicity from GVHD. J. Pediatr. Hematol. Oncol. 40 e364–e368. 10.1097/MPH.0000000000001227
    1. DeVincenzo J. P., McClure M. W., Symons J. A., Fathi H., Westland C., Chanda S., et al. (2015). Activity of oral ALS-008176 in a respiratory syncytial virus challenge study. N. Engl. J. Med. 373 2048–2058. 10.1056/NEJMoa1413275
    1. DeVincenzo J. P., Whitley R. J., Mackman R. L., Scaglioni-Weinlich C., Harrison L., Farrell E., et al. (2014). Oral GS-5806 activity in a respiratory syncytial virus challenge study. N. Engl. J. Med. 371 711–722. 10.1056/NEJMoa1401184
    1. Dhakal B., D’Souza A., Pasquini M., Saber W., Fenske T. S., Moss R. B., et al. (2016). DAS181 treatment of severe parainfluenza virus 3 pneumonia in allogeneic hematopoietic stem cell transplant recipients requiring mechanical ventilation. Case Rep. Med. 2016:8503275. 10.1155/2016/8503275
    1. Ditt V., Viazov S., Tillmann R., Schildgen V., Schildgen O. (2008). Genotyping of human bocavirus using a restriction length polymorphism. Virus Genes 36 67–69. 10.1007/s11262-007-0182-0
    1. Donohoe D. R., Garge N., Zhang X., Sun W., O’Connell T. M., Bunger M. K., et al. (2011). The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 13 517–526. 10.1016/j.cmet.2011.02.018
    1. Dyer K. D., Drummond R. A., Rice T. A., Percopo C. M., Brenner T. A., Barisas D. A., et al. (2016). Priming of the respiratory tract with immunobiotic Lactobacillus plantarum limits infection of alveolar macrophages with recombinant pneumonia virus of mice (rK2-PVM). J. Virol. 90 979–991. 10.1128/JVI.02279-15
    1. Edner N., Castillo-Rodas P., Falk L., Hedman K., Soderlund-Venermo M., Allander T. (2012). Life-threatening respiratory tract disease with human bocavirus-1 infection in a 4-year-old child. J. Clin. Microbiol. 50 531–532. 10.1128/JCM.05706-11
    1. Elemraid M. A., Muller M., Spencer D. A., Rushton S. P., Gorton R., Thomas M. F., et al. (2014). Accuracy of the interpretation of chest radiographs for the diagnosis of paediatric pneumonia. PLoS One 9:e106051. 10.1371/journal.pone.0106051
    1. Engelhard D., Mohty B., de la Camara R., Cordonnier C., Ljungman P. (2013). European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transplant. Infect. Dis. 15 219–32. 10.1111/tid.12054
    1. Englund J., Feuchtinger T., Ljungman P. (2011). Viral infections in immunocompromised patients. Biol. Blood Marrow Transplant. 17 S2–S5. 10.1016/j.bbmt.2010.11.008
    1. Englund J. A., Boeckh M., Kuypers J., Nichols W. G., Hackman R. C., Morrow R., et al. (2006). Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann. Int. Med. 144 344–349. 10.7326/0003-4819-144-5-200603070-00010
    1. Englund J. A., Champlin R. E., Wyde P. R., Kantarjian H., Atmar R. L., Tarrand J., et al. (1998). Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 26 1418–1424. 10.1086/516358
    1. Feghoul L., Chevret S., Cuinet A., Dalle J.-H., Ouachée M., Yacouben K., et al. (2015). Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 21 701–709. 10.1016/j.cmi.2015.03.011
    1. Feucht J., Opherk K., Lang P., Kayser S., Hartl L., Bethge W., et al. (2015). Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT. Blood 125 1986–1994. 10.1182/blood-2014-06-573725
    1. Feuchtinger T., Lang P., Handgretinger R. (2007). Adenovirus infection after allogeneic stem cell transplantation. Leuk Lymphoma 48 244–255. 10.1080/10428190600881157
    1. Feuchtinger T., Matthes-Martin S., Richard C., Lion T., Fuhrer M., Hamprecht K., et al. (2006). Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br. J. Haematol. 134 64–76. 10.1111/j.1365-2141.2006.06108.x
    1. Fiore A. E., Fry A., Shay D., Gubareva L., Bresee J. S., Uyeki T. M., et al. (2011). Antiviral agents for the treatment and chemoprophylaxis of influenza — recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep. Morb. Mortal. Wkly. Rep. Recomm. Rep. 60 1–24.
    1. Franquet T. (2018). Imaging of community-acquired pneumonia. J. Thorac Imaging. 33 282–294. 10.1097/RTI.0000000000000347
    1. Franquet T., Rodriguez S., Martino R., Gimenez A., Salinas T., Hidalgo A. (2006). Thin-section CT findings in hematopoietic stem cell transplantation recipients with respiratory virus pneumonia. AJR Am. J. Roentgenol. 187 1085–1090. 10.2214/AJR.05.0439
    1. Gerdemann U., Katari U. L., Papadopoulou A., Keirnan J. M., Craddock J. A., Liu H., et al. (2013). Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol. Ther. J. Am. Soc. Gene Ther. 21 2113–2121. 10.1038/mt.2013.151
    1. Gerdemann U., Keirnan J. M., Katari U. L., Yanagisawa R., Christin A. S., Huye L. E., et al. (2012). Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections. Mol. Ther. J. Am. Soc. Gene Ther. 20 1622–1632. 10.1038/mt.2012.130
    1. Gorcea C. M., Tholouli E., Turner A., Saif M., Davies E., Battersby E., et al. (2017). Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients. J. Hosp. Infect. 95 214–217. 10.1016/j.jhin.2016.11.012
    1. Grimley M. S., Chemaly R. F., Englund J. A., Kurtzberg J., Chittick G., Brundage T. M., et al. (2017). Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial. Biol. Blood Marrow Transplant. 23 512–521. 10.1016/j.bbmt.2016.12.621
    1. Gutman J. A., Peck A. J., Kuypers J., Boeckh M. (2007). Rhinovirus as a cause of fatal lower respiratory tract infection in adult stem cell transplantation patients: a report of two cases. Bone Marrow Transplant. 40 809–811. 10.1038/sj.bmt.1705827
    1. Haak B. W., Littmann E. R., Chaubard J. L., Pickard A. J., Fontana E., Adhi F., et al. (2018). Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood 131 2978–2986. 10.1182/blood-2018-01-828996
    1. Hamelin M.-E., Gagnon C., Prince G. A., Kiener P., Suzich J., Ulbrandt N., et al. (2010). Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model. Antivir. Res. 88 31–37. 10.1016/j.antiviral.2010.07.001
    1. Herbst T., Van Deerlin V. M., Miller W. T. (2013). The CT appearance of lower respiratory infection due to parainfluenza virus in adults. AJR Am. J. Roentgenol. 201 550–554. 10.2214/AJR.12.9613
    1. Hilmes M. A., Daniel Dunnavant F., Singh S. P., Ellis W. D., Payne D. C., Zhu Y., et al. (2017). Chest radiographic features of human metapneumovirus infection in pediatric patients. Pediatr. Radiol. 47 1745–1750. 10.1007/s00247-017-3943-5
    1. Hirsch H. H., Martino R., Ward K. N., Boeckh M., Einsele H., Ljungman P. (2013). Fourth European conference on infections in leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin. Infect. Dis. 56 258–266. 10.1093/cid/cis844
    1. Hiwarkar P., Amrolia P., Sivaprakasam P., Lum S. H., Doss H., O’Rafferty C., et al. (2017). Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant. Blood 129 2033–2037. 10.1182/blood-2016-11-749721
    1. Hiwarkar P., Kosulin K., Cesaro S., Mikulska M., Styczynski J., Wynn R., et al. (2018). Management of adenovirus infection in patients after haematopoietic stem cell transplantation: state-of-the-art and real-life current approach: a position statement on behalf of the infectious diseases working party of the european society of blood and marrow transplantation. Rev. Med. Virol. 28:e1980. 10.1002/rmv.1980
    1. Hodson A., Kasliwal M., Streetly M., MacMahon E., Raj K. (2011). A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality. Bone Marrow Transplant. 46 1545–1550. 10.1038/bmt.2010.347
    1. Hoellein A., Hecker J., Hoffmann D., Göttle F., Protzer U., Peschel C., et al. (2016). Serious outbreak of human metapneumovirus in patients with hematologic malignancies. Leuk. Lymphoma 57 623–627. 10.3109/10428194.2015.1067699
    1. Huang H. S., Tsai C. L., Chang J., Hsu T. C., Lin S., Lee C. C. (2017). Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis. Clin. Microbiol. Infect. 24 1055–1063. 10.1016/j.cmi.2017.11.018
    1. Icheva V., Kayser S., Wolff D., Tuve S., Kyzirakos C., Bethge W., et al. (2013). Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 31 39–48. 10.1200/JCO.2011.39.8495
    1. Ichinohe T., Pang I. K., Kumamoto Y., Peaper D. R., Ho J. H., Murray T. S., et al. (2011). Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U.S.A. 108 5354–5359. 10.1073/pnas.1019378108
    1. Ison M. G., Hayden F. G., Kaiser L., Corey L., Boeckh M. (2003). Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin. Infect. Dis. 36 1139–1143. 10.1086/374340
    1. Jacobs S. E., Soave R., Shore T. B., Satlin M. J., Schuetz A. N., Magro C., et al. (2013). Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients. Transplant. Infect. Dis. 15 474–486. 10.1111/tid.12111
    1. Kanne J. P., Godwin J. D., Franquet T., Escuissato D. L., Muller N. L. (2007). Viral pneumonia after hematopoietic stem cell transplantation: high-resolution CT findings. J. Thorac. Imaging 22 292–299. 10.1097/RTI.0b013e31805467f4
    1. Kapoor A., Hornig M., Asokan A., Williams B., Henriquez J. A., Lipkin W. I. (2011). Bocavirus episome in infected human tissue contains non-identical termini. PLoS One 6:e21362. 10.1371/journal.pone.0021362
    1. Kapoor A., Simmonds P., Slikas E., Li L., Bodhidatta L., Sethabutr O., et al. (2010). Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections. J. Infect. Dis. 201 1633–1643. 10.1086/652416
    1. Kelly S. G., Metzger K., Bolon M. K., Silkaitis C., Mielnicki M., Cullen J., et al. (2016). Respiratory syncytial virus outbreak on an adult stem cell transplant unit. Am. J. Infect. Control 44 1022–1026. 10.1016/j.ajic.2016.03.075
    1. Khanna N., Steffen I., Studt J. D., Schreiber A., Lehmann T., Weisser M., et al. (2009). Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transplant. Infect. Dis. 11 100–105. 10.1111/j.1399-3062.2008.00362.x
    1. Khanna N., Widmer A. F., Decker M., Steffen I., Halter J., Heim D., et al. (2008). Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin. Infect. Dis. 46 402–412. 10.1086/525263
    1. Kim M. C., Kim M. Y., Lee H. J., Lee S. O., Choi S. H., Kim Y. S., et al. (2016). CT findings in viral lower respiratory tract infections caused by parainfluenza virus, influenza virus and respiratory syncytial virus. Med. Baltim. 95:e4003. 10.1097/MD.0000000000004003
    1. Kim Y. J., Guthrie K. A., Waghmare A., Walsh E. E., Falsey A. R., Kuypers J., et al. (2014). Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease. J. Infect. Dis. 209 1195–1204. 10.1093/infdis/jit832
    1. Kim Y.-J., Waghmare A., Kuypers J. M., Jerome K. R., Pergam S. A., Xie H., et al. (2017). Impact of pretransplant respiratory virus detection through universal screening in children undergoing hematopoietic cell transplantation (HCT). Biol. Blood Marrow Transplant. 23 S190–S191. 10.1016/j.bbmt.2016.12.370
    1. Kishi Y., Kami M., Oki Y., Kazuyama Y., Kawabata M., Miyakoshi S., et al. (2000). Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation. Bone Marrow Transplant. 26 573–576. 10.1038/sj.bmt.1702559
    1. Kmeid J., Vanichanan J., Shah D. P., El Chaer F., Azzi J., Ariza-Heredia E. J., et al. (2016). Outcomes of influenza infections in hematopoietic cell transplant recipients: application of an immunodeficiency scoring index. Biol. Blood Marrow Transplant. 22 542–548. 10.1016/j.bbmt.2015.11.015
    1. Kohlmeier J. E., Woodland D. L. (2009). Immunity to respiratory viruses. Annu. Rev. Immunol. 27 61–82. 10.1146/annurev.immunol.021908.132625
    1. Koskenvuo M., Mottonen M., Waris M., Allander T., Salmi T. T., Ruuskanen O. (2008). Human bocavirus in children with acute lymphoblastic leukemia. Eur. J. Pediatr. 167 1011–1015. 10.1007/s00431-007-0631-8
    1. Kosulin K., Berkowitsch B., Matthes S., Pichler H., Lawitschka A., Potschger U., et al. (2018a). Intestinal adenovirus shedding before allogeneic stem cell transplantation is a risk factor for invasive infection post-transplant. EBioMedicine 28 114–119. 10.1016/j.ebiom.2017.12.030
    1. Kosulin K., Lam E., Heim A., Dobner T., Rodriguez E. (2018b). Broad-spectrum antiviral activity of the deubiquitinase inhibitor HBX against human adenoviruses. Antivir. Ther. 23 475–483. 10.3851/IMP3230
    1. Kupfer B., Vehreschild J., Cornely O., Kaiser R., Plum G., Viazov S., et al. (2006). Severe pneumonia and human bocavirus in adult. Emerg. Infect. Dis. 12 1614–1616. 10.3201/eid1210.060520
    1. Lalayanni C., Sirigou A., Iskas M., Smias C., Sakellari I., Anagnostopoulos A. (2010). Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome. J. Infect. 61 270–272. 10.1016/j.jinf.2010.06.013
    1. Lankester A. C., Heemskerk B., Claas E. C. J., Schilham M. W., Beersma M. F. C., Bredius R. G. M., et al. (2004). Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 38 1521–1525. 10.1086/420817
    1. Leber A. L., Everhart K., Daly J. A., Hopper A., Harrington A., Schreckenberger P., et al. (2018). Multicenter evaluation of biofire filmarray respiratory panel 2 for detection of viruses and bacteria in nasopharyngeal swab samples. J. Clin. Microbiol. 56:e01945-17. 10.1128/JCM.01945-17
    1. Leen A. M., Bollard C. M., Myers G. D., Rooney C. M. (2006). Adenoviral infections in hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 12 243–251. 10.1016/j.bbmt.2005.10.024
    1. Lindemans C. A., Leen A. M., Boelens J. J. (2010). How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood 116 5476–5485. 10.1182/blood-2010-04-259291
    1. Lion T. (2014). Adenovirus infections in immunocompetent and immunocompromised patients. Clin. Microbiol. Rev. 27 441–462. 10.1128/CMR.00116-13
    1. Ljungman P. (1997). Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am. J. Med. 102 44–47. 10.1016/S0002-9343(97)00010-7
    1. Ljungman P., de la Camara R., Perez-Bercoff L., Abecasis M., Nieto Campuzano J. B., Cannata-Ortiz M. J., et al. (2011). Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica 96 1231–1235. 10.3324/haematol.2011.041913
    1. Ljungman P., Ward K. N., Crooks B. N., Parker A., Martino R., Shaw P. J., et al. (2001). Respiratory virus infections after stem cell transplantation: a prospective study from the infectious diseases working party of the European Group for blood and marrow transplantation. Bone Marrow Transplant. 28 479–484. 10.1038/sj.bmt.1703139
    1. Lo M. S., Lee G. M., Gunawardane N., Burchett S. K., Lachenauer C. S., Lehmann L. E. (2013). The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr. Transplant. 17 133–143. 10.1111/petr.12022
    1. Martin E. T., Kuypers J., McRoberts J. P., Englund J. A., Zerr D. M. (2015). Human bocavirus 1 primary infection and shedding in infants. J. Infect. Dis. 212 516–524. 10.1093/infdis/jiv044
    1. Martino R., Porras R. P., Rabella N., Williams J. V., Ramila E., Margall N., et al. (2005). Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol. Blood Marrow Transplant. 11 781–796. 10.1016/j.bbmt.2005.07.007
    1. Mayer J. L., Lehners N., Egerer G., Kauczor H. U., Heussel C. P. (2014). CT-morphological characterization of respiratory syncytial virus (RSV) pneumonia in immune-compromised adults. Rofo 186 686–692. 10.1055/s-0033-1356353
    1. Maziarz R. T., Sridharan P., Slater S., Meyers G., Post M., Erdman D. D., et al. (2010). Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients. Biol. Blood Marrow Transplant. 16 192–198. 10.1016/j.bbmt.2009.09.014
    1. McLaughlin L. P., Lang H., Williams E., Wright K. E., Powell A., Cruz C. R., et al. (2016). Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes. Cytotherapy 18 1515–1524. 10.1016/j.jcyt.2016.08.010
    1. Meijer A., Lackenby A., Hungnes O., Lina B., van-der-Werf S., Schweiger B., et al. (2009). Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg. Infect. Dis. 15 552–560. 10.3201/eid1504.181280
    1. Memoli M. J., Hrabal R. J., Hassantoufighi A., Eichelberger M. C., Taubenberger J. K. (2010). Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 50 1252–1255. 10.1086/651605
    1. Milano F., Campbell A. P., Guthrie K. A., Kuypers J., Englund J. A., Corey L., et al. (2010). Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients. Blood 115 2088–2094. 10.1182/blood-2009-09-244152
    1. Moe N., Krokstad S., Stenseng I. H., Christensen A., Skanke L. H., Risnes K. R., et al. (2017). Comparing human metapneumovirus and respiratory syncytial virus: viral co-detections, genotypes and risk factors for severe disease. PLoS One 12:e0170200. 10.1371/journal.pone.0170200
    1. Morfin F., Dupuis-Girod S., Mundweiler S., Falcon D., Carrington D., Sedlacek P., et al. (2005). In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir. Ther. 10 225–229.
    1. Neofytos D., Ojha A., Mookerjee B., Wagner J., Filicko J., Ferber A., et al. (2007). Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol. Blood Marrow Transplant. 13 74–81. 10.1016/j.bbmt.2006.08.040
    1. Nichols W. G., Corey L., Gooley T. A., Davis C., Boeckh M. (2001a). Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 98 573–578. 10.1182/blood.V98.3.573
    1. Nichols W. G., Gooley T., Boeckh M. (2001b). Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the fred hutchinson cancer research center experience. Biol. Blood Marrow Transplant. 7 11S–15S. 10.1053/bbmt.2001.v7.pm11777098
    1. Nichols W. G., Erdman D. D., Han A., Zukerman C., Corey L., Boeckh M. (2004a). Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis. Biol. Blood Marrow Transplant. 10 58–64. 10.1016/j.bbmt.2003.09.010
    1. Nichols W. G., Guthrie K. A., Corey L., Boeckh M. (2004b). Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin. Inf. Dis. 39 1300–1306. 10.1086/425004
    1. Ogimi C., Greninger A. L., Waghmare A. A., Kuypers J. M., Shean R. C., Xie H., et al. (2017a). Prolonged shedding of human coronavirus in hematopoietic cell transplant recipients: risk factors and viral genome evolution. J. Infect. Dis. 216 203–209. 10.1093/infdis/jix264
    1. Ogimi C., Waghmare A. A., Kuypers J. M., Xie H., Yeung C. C., Leisenring W. M., et al. (2017b). Clinical significance of human coronavirus in bronchoalveolar lavage samples from hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin. Infect. Dis. 64 1532–1539. 10.1093/cid/cix160
    1. Ogimi C., Krantz E. M., Golob J. L., Waghmare A., Liu C., Leisenring W. M., et al. (2018a). Antibiotic exposure prior to respiratory viral infection is associated with progression to lower respiratory tract disease in allogeneic hematopoietic cell transplant recipients. Biol. Blood Marrow Transplant. 24 2293–2301. 10.1016/j.bbmt.2018.05.016
    1. Ogimi C., Xie H., Leisenring W. M., Kuypers J. M., Jerome K. R., Campbell A. P., et al. (2018b). Initial high viral load is associated with prolonged shedding of human rhinovirus in allogeneic hematopoietic cell transplant recipients. Biol. Blood Marrow Transplant. 24 2160–2163. 10.1016/j.bbmt.2018.07.006
    1. Parody R., Rabella N., Martino R., Otegui M., del Cuerpo M., Coll P., et al. (2007). Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies. Am. J. Hematol. 82 807–811. 10.1002/ajh.20974
    1. Peck A. J., Corey L., Boeckh M. (2004). Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation. Clin. Infect. Dis. 39 673–680. 10.1086/422994
    1. Peck A. J., Englund J. A., Kuypers J., Guthrie K. A., Corey L., Morrow R., et al. (2007). Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 110 1681–1688. 10.1182/blood-2006-12-060343
    1. Peggs K. S., Thomson K., Samuel E., Dyer G., Armoogum J., Chakraverty R., et al. (2011). Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 52 49–57. 10.1093/cid/ciq042
    1. Peggs K. S., Verfuerth S., Pizzey A., Khan N., Guiver M., Moss P. A., et al. (2003). Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet Lond. Engl. 362 1375–1377. 10.1016/S0140-6736(03)14634-X
    1. Pinana J. L., Gomez M. D., Perez A., Madrid S., Balaguer-Rosello A., Gimenez E., et al. (2018). Community acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: risk factors and mortality from pulmonary virus-bacterial mixed infections. Transplant. Infect. Dis. 20:e12926. 10.1111/tid.12926
    1. Protheroe R. E., Kirkland K. E., Pearce R. M., Kaminaris K., Bloor A., Potter M. N., et al. (2012). The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British society of blood and marrow transplantation study. Bone Marrow Transplant. 47 88–94. 10.1038/bmt.2011.12
    1. Qian C., Campidelli A., Wang Y., Cai H., Venard V., Jeulin H., et al. (2017). Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial. J. Hematol. Oncol. 10:102. 10.1186/s13045-017-0469-0
    1. Ramsay I. D., Attwood C., Irish D., Griffiths P. D., Kyriakou C., Lowe D. M. (2017). Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir – Case series and 10 year experience of management in an adult transplant cohort. J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. 96 73–79. 10.1016/j.jcv.2017.09.013
    1. Renaud C., Campbell A. P. (2011). Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients. Curr. Opin. Infect. Dis. 24 333–343. 10.1097/QCO.0b013e3283480440
    1. Renaud C., Englund J. A. (2012). Antiviral therapy of respiratory viruses in haematopoietic stem cell transplant recipients. Antivir. Ther. 17 175–191. 10.3851/IMP2060)
    1. Renaud C., Xie H., Seo S., Kuypers J., Cent A., Corey L., et al. (2013). Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplant recipients. Biol. Blood Marrow Transplant. 19 1220–1226. 10.1016/j.bbmt.2013.05.005
    1. Salvatore M., Satlin M. J., Jacobs S. E., Jenkins S. G., Schuetz A. N., Moss R. B., et al. (2016). DAS181 for treatment of parainfluenza virus infections in hematopoietic stem cell transplant recipients at a single center. Biol. Blood Marrow Transplant. 22 965–970. 10.1016/j.bbmt.2016.02.011
    1. Sam S. S., Caliendo A. M., Ingersoll J., Abdul-Ali D., Hill C. E., Kraft C. S. (2018). Evaluation of performance characteristics of panther fusion assays for detection of respiratory viruses from nasopharyngeal and lower respiratory tract specimens. J. Clin. Microbiol. 56:e00787-18. 10.1128/JCM.00787-18
    1. Schenk T., Strahm B., Kontny U., Hufnagel M., Neumann-Haefelin D., Falcone V. (2007). Disseminated bocavirus infection after stem cell transplant. Emerg. Infect. Dis. 13 1425–1427. 10.3201/eid1309.070318
    1. Schiffer J. T., Kirby K., Sandmaier B., Storb R., Corey L., Boeckh M. (2009). Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation. Haematologica 94 1101–1108. 10.3324/haematol.2008.003186
    1. Schildgen O., Muller A., Allander T., Mackay I. M., Volz S., Kupfer B., et al. (2008). Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin. Microbiol. Rev. 21 291–304. 10.1128/CMR.00030-07
    1. Schleuning M., Buxbaum-Conradi H., Jäger G., Kolb H.-J. (2004). Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. Hematol. J. Off. J. Eur. Haematol. Assoc. 5 135–144. 10.1038/sj.thj.6200358
    1. Schmidt M. E., Varga S. M. (2018). The CD8 T cell response to respiratory virus infections. Front. Immunol. 9:678. 10.3389/fimmu.2018.00678
    1. Schub A., Schuster I. G., Hammerschmidt W., Moosmann A. (2009). CMV-specific TCR-transgenic T cells for immunotherapy. J. Immunol. Baltim. Md. 1950 6819–6830. 10.4049/jimmunol.0902233
    1. Semple M. G., Cowell A., Dove W., Greensill J., McNamara P. S., Halfhide C., et al. (2005). Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J. Infect. Dis. 191 382–386. 10.1086/426457
    1. Senior K. (2002). FDA panel rejects common cold treatment. Lancet Infect. Dis. 2:264. 10.1016/S1473-3099(02)00277-3
    1. Seo S., Campbell A. P., Xie H., Chien J. W., Leisenring W. M., Englund J. A., et al. (2013). Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement. Biol. Blood Marrow Transplant. 19 589–596. 10.1016/j.bbmt.2012.12.019
    1. Seo S., Gooley T. A., Kuypers J. M., Stednick Z., Jerome K. R., Englund J. A., et al. (2016). Human metapneumovirus infections following hematopoietic cell transplantation: factors associated with disease progression. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 63 178–185. 10.1093/cid/ciw284
    1. Seo S., Waghmare A., Scott E. M., Xie H., Kuypers J. M., Hackman R. C., et al. (2017). Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality. Haematologica 102 1120–1130. 10.3324/haematol.2016.153767
    1. Seo S., Xie H., Campbell A. P., Kuypers J. M., Leisenring W. M., Englund J. A., et al. (2014a). Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 58 1357–1368. 10.1093/cid/ciu134
    1. Seo S., Xie H., Karron R. A., Thumar B., Englund J. A., Leisenring W. M., et al. (2014b). Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes. Bone Marrow Transplant. 49 1205–1211. 10.1038/bmt.2014.124
    1. Shah D. P., Ghantoji S. S., Ariza-Heredia E. J., Shah J. N., El Taoum K. K., Shah P. K., et al. (2014). Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood 123 3263–3268. 10.1182/blood-2013-12-541359
    1. Shah D. P., Ghantoji S. S., Shah J. N., El Taoum K. K., Jiang Y., Popat U., et al. (2013). Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. J. Antimicrob. Chemother. 68 1872–1880. 10.1093/jac/dkt111
    1. Shah D. P., Shah P. K., Azzi J. M., Chemaly R. F. (2016a). Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review. Cancer Lett. 370 358–364. 10.1016/j.canlet.2015.11.014
    1. Shah D. P., Shah P. K., Azzi J. M., El Chaer F., Chemaly R. F. (2016b). Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review. Cancer Lett. 379 100–106. 10.1016/j.canlet.2016.05.035
    1. Shah J. N., Chemaly R. F. (2011). Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood 117 2755–2763. 10.1182/blood-2010-08-263400
    1. Shahani L., Ariza-Heredia E. J., Chemaly R. F. (2017). Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev. Antivir. Infect. Ther. 15 401–415. 10.1080/14787210.2017.1279970
    1. Sheshadri A., Shah D. P., Godoy M., Erasmus J. J., Song J., Li L., et al. (2018). Progression of the radiologic severity index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections. PLoS One 13:e0197418. 10.1371/journal.pone.0197418
    1. Simões E. A. F., DeVincenzo J. P., Boeckh M., Bont L., Crowe J. E., Griffiths P., et al. (2015). Challenges and opportunities in developing respiratory syncytial virus therapeutics. J. Infect. Dis. 211 S1–S20. 10.1093/infdis/jiu828
    1. Spahr Y., Tschudin-Sutter S., Baettig V., Compagno F., Tamm M., Halter J., et al. (2018). Community-acquired respiratory paramyxovirus infection after allogeneic hematopoietic cell transplantation: a single-center experience. Open Forum Infect. Dis. 5:ofy077. 10.1093/ofid/ofy077
    1. Srinivasan A., Wang C., Yang J., Shenep J. L., Leung W. H., Hayden R. T. (2011). Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 17 1520–1527. 10.1016/j.bbmt.2011.03.001
    1. Sung A. D., Sung J. A. M., Thomas S., Hyslop T., Gasparetto C., Long G., et al. (2016). Universal mask usage for reduction of respiratory viral infections after stem cell transplant: a prospective trial. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 63 999–1006. 10.1093/cid/ciw451
    1. Suyani E., Aki Z., Guzel O., Altindal S., Senol E., Sucak G. (2011). H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy might be life saving. Transplant. Infect. Dis. 13 208–212. 10.1111/j.1399-3062.2010.00569.x
    1. Syha R., Beck R., Hetzel J., Ketelsen D., Grosse U., Springer F., et al. (2012). Human metapneumovirus (HMPV) associated pulmonary infections in immunocompromised adults–initial CT findings, disease course and comparison to respiratory-syncytial-virus (RSV) induced pulmonary infections. Eur. J. Radiol. 81 4173–4178. 10.1016/j.ejrad.2012.06.024
    1. Taniguchi K., Yoshihara S., Tamaki H., Fujimoto T., Ikegame K., Kaida K., et al. (2012). Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation. Ann. Hematol. 91 1305–1312. 10.1007/s00277-012-1440-3
    1. Tomblyn M., Chiller T., Einsele H., Gress R., Sepkowitz K., Storek J., et al. (2009). Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol. Blood Marrow Transplant. 15 1143–1238. 10.1016/j.bbmt.2009.06.019
    1. Tzannou I., Papadopoulou A., Naik S., Leung K., Martinez C. A., Ramos C. A., et al. (2017). Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, epstein-barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 35 3547–3557. 10.1200/JCO.2017.73.0655
    1. Ulbrandt N. D., Ji H., Patel N. K., Riggs J. M., Brewah Y. A., Ready S., et al. (2006). Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J. Virol. 80 7799–7806. 10.1128/JVI.00318-06
    1. Ursic T., Steyer A., Kopriva S., Kalan G., Krivec U., Petrovec M. (2011). Human bocavirus as the cause of a life-threatening infection. J. Clin. Microbiol. 49 1179–1181. 10.1128/JCM.02362-10
    1. Ustun C., Slaby J., Shanley R. M., Vydra J., Smith A. R., Wagner J. E., et al. (2012). Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time. Biol. Blood Marrow Transplant. 18 1580–1588. 10.1016/j.bbmt.2012.04.012
    1. van den Hoogen B. G., de Jong J. C., Groen J., Kuiken T., de Groot R., Fouchier R. A., et al. (2001). A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7 719–724. 10.1038/89098
    1. van der Hoek L., Pyrc K., Jebbink M. F., Vermeulen-Oost W., Berkhout R. J., Wolthers K. C., et al. (2004). Identification of a new human coronavirus. Nat. Med. 10 368–373. 10.1038/nm1024
    1. Versluys A. B., Rossen J. W. A., van Ewijk B., Schuurman R., Bierings M. B., Boelens J. J. (2010). Strong association between respiratory viral infection early after hematopoietic stem cell transplantation and the development of life-threatening acute and chronic alloimmune lung syndromes. Biol. Blood Marrow Transplant. 16 782–791. 10.1016/j.bbmt.2009.12.534
    1. von Lilienfeld-Toal M., Berger A., Christopeit M., Hentrich M., Heussel C. P., Kalkreuth J., et al. (2016). Community acquired respiratory virus infections in cancer patients-guideline on diagnosis and management by the infectious diseases working party of the german society for haematology and medical oncology. Eur. J. Cancer 67 200–212. 10.1016/j.ejca.2016.08.015
    1. Vu D., Peck A. J., Nichols W. G., Varley C., Englund J. A., Corey L., et al. (2007). Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 45 187–193. 10.1086/518985
    1. Waghmare A., Campbell A. P., Xie H., Seo S., Kuypers J., Leisenring W., et al. (2013). Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 57 1731–1741. 10.1093/cid/cit639
    1. Waghmare A., Englund J. A., Boeckh M. (2016). How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation. Blood 127 2682–2692. 10.1182/blood-2016-01-634873
    1. Waghmare A., Wagner T., Andrews R., Smith S., Kuypers J., Boeckh M., et al. (2015). Successful treatment of parainfluenza virus respiratory tract infection with DAS181 in 4 immunocompromised children. J. Pediatr. Infect. Soc. 4 114–118. 10.1093/jpids/piu039
    1. Wang K., Wang W., Yan H., Ren P., Zhang J., Shen J., et al. (2010). Correlation between bocavirus infection and humoral response, and co-infection with other respiratory viruses in children with acute respiratory infection. J. Clin. Virol. 47 148–155. 10.1016/j.jcv.2009.11.015
    1. Wen S. C., Williams J. V. (2015). New approaches for immunization and therapy against human metapneumovirus. Clin. Vaccine Immunol. 22 858–866. 10.1128/CVI.00230-15
    1. Whimbey E., Elting L. S., Couch R. B., Lo W., Williams L., Champlin R. E., et al. (1994). Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant. 13 437–440.
    1. Williams J. V., Martino R., Rabella N., Otegui M., Parody R., Heck J. M., et al. (2005). A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J. Infect. Dis. 192 1061–1065. 10.1086/432732
    1. Wolfromm A., Porcher R., Legoff J., Peffault, de Latour R., Xhaard al. (2014). Viral respiratory infections diagnosed by multiplex PCR after allogeneic hematopoietic stem cell transplantation: long-term incidence and outcome. Biol. Blood Marrow Transplant. 20 1238–1241. 10.1016/j.bbmt.2014.04.004
    1. Woo P. C., Lau S. K., Chu C. M., Chan K. H., Tsoi H. W., Huang Y., et al. (2005). Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 79 884–895. 10.1128/JVI.79.2.884-895.2005
    1. Ip W. W., Qasim W. (2013). Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation. Adv. Hematol. 2013:176418. 10.1155/2013/176418
    1. Yan X. L., Li Y. N., Tang Y. J., Xie Z. P., Gao H. C., Yang X. M., et al. (2017). Clinical characteristics and viral load of respiratory syncytial virus and human metapneumovirus in children hospitaled for acute lower respiratory tract infection. J. Med. Virol. 89 589–597. 10.1002/jmv.24687
    1. Yilmaz M., Chemaly R. F., Han X. Y., Thall P. F., Fox P. S., Tarrand J. J., et al. (2013). Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant. 48 1218–1223. 10.1038/bmt.2013.33

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren